Home » Topics » Medical technology

Medical technology
RSS

MedImmune Starts Enrolling Pivotal Phase III Numax Trial

Nov. 2, 2004

News From AASLD

Nov. 2, 2004

Hemispherx Gears Up For NDA With Ampligen Data

Nov. 2, 2004

Effects Impressive, Mechanism Elusive For Endocannabinoids

Nov. 1, 2004

By Anette Breindl

Acquisitions

Nov. 1, 2004

Acquisitions

Nov. 1, 2004

Conor Medsystems reports early results from COSTAR I

Nov. 1, 2004

Product Briefs: SynCardia device OK for bridge-to-transplant

Nov. 1, 2004

Stock Winners and Losers For The Week

Nov. 1, 2004

Product Pipeline: SynCardia's heart wins bridge-to-transplant OK

Nov. 1, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...